FilingSEC EDGAR6-K
Alterity Therapeutics Files 2026 Corporate Governance Statement
· SEC accepted
StageDisclosure
Filing content
The company filed its 2026 Corporate Governance Statement disclosing compliance with ASX recommendations.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…